Sandbox:Maneesha: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__


==Epidemiology and Demographics===
==Epidemiology and Demographics==


===Incidence===
===Incidence===
The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*The annual incidence of Pleomorphic adenoma  is approximately 2-3.5 cases per 100,000 population.<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref>
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*It accounts for 45-75% of all salivary gland neoplasms.
===Prevalence===
===Age===
The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*Patients of all age groups may develop Pleomorphic adenoma.<ref name="pmid">{{cite journal |vauthors=Pinkston JA, Cole P |title=Incidence rates of salivary gland tumors: results from a population-based study |journal=Otolaryngol Head Neck Surg |volume=120 |issue=6 |pages=834–40 |date=June 1999 |pmid= |doi=10.1016/S0194-5998(99)70323-2 |url=}}</ref>
In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The incidence of Pleomorphic adenoma increases with age; the average age at diagnosis is 43-46 years.
The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
===Race===
Case-fatality rate/Mortality rate
There is no racial predilection to Pleomorphic adenoma.
In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
===Gender===
The case-fatality rate/mortality rate of [disease name] is approximately [number range].
*Females are predominantly affected by Pleomorphic adenoma than males. The female to male ratio is approximately (2:1)
Age
Patients of all age groups may develop [disease name].
The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
[Chronic disease name] is usually first diagnosed among [age group].
[Acute disease name] commonly affects [age group].
Race
There is no racial predilection to [disease name].
[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
[Disease name] affects men and women equally.
[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
The majority of [disease name] cases are reported in [geographical region].
[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries





Revision as of 20:26, 8 January 2019


Epidemiology and Demographics

Incidence

  • The annual incidence of Pleomorphic adenoma is approximately 2-3.5 cases per 100,000 population.[1]
  • It accounts for 45-75% of all salivary gland neoplasms.

Age

  • Patients of all age groups may develop Pleomorphic adenoma.[1]
  • The incidence of Pleomorphic adenoma increases with age; the average age at diagnosis is 43-46 years.

Race

There is no racial predilection to Pleomorphic adenoma.

Gender

  • Females are predominantly affected by Pleomorphic adenoma than males. The female to male ratio is approximately (2:1)


\

References=

  1. 1.0 1.1 Pinkston JA, Cole P (June 1999). "Incidence rates of salivary gland tumors: results from a population-based study". Otolaryngol Head Neck Surg. 120 (6): 834–40. doi:10.1016/S0194-5998(99)70323-2.